Peter Joyce
Company: Grey Wolf Therapeutics Ltd.
Seminars:
1:00 pm Targeting ERAP1: Altering Neoantigen Presentation With a Small Molecule
Seminar_day: Day One
Company: Grey Wolf Therapeutics Ltd.
Seminar_day: Day One